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For all the angst over medical malpractice litigation in developed
countries like the United States, very little has been written about it
in the developing world. Developing countries account for more
than 80% of the world's population,' but they are often an after-
thought in comparative health law literature. 2 Noteworthy compara-
tive compilations include either very few developing countries or
none at all. For example, the iconic treatise International Medical Mal-
practice Law by Dieter Giesen focuses mostly on wealthy, developed
countries like our own.' And the more recent corpus of comparative
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1. The United Nations estimates that only 18% of the world's population (or 1.2 billion out
of 6.9 billion people) live in "more developed" regions. World Population Prospects, the 2010 Re-
vision, U.N., DEP"T OF ECON. & Soc. AFFAIRS, POPULATION Div., POPULATION ESTIMATES & PRO-
JECTIONS SECTION, http://esa.un.org/unpd/wpp/unpp/panel population.htm (last visited
Dec. 6, 2011) (select "Population" under "Select Variables"; then select "More developed re-
gions" under "Select Country/Region"; then select "All variants" under "Select Variant"; then
select "2010" under both "Start Year" and "End Year"; then click "Display"). The remaining
82 percent of the population (5.7 billion) live in "less developed" ones. Id. (submit same query
as previous cite, except select "Less developed regions" under "Select Country/Region").
2. See Barbara McPake & Anne Mills, What Can We Learn from International Comparisons of
Health Systems and Health System Reform?, 78 BULL. WORLD HEALTH ORG. 811, 817 (2000), avail-
able at http://www.who.int/bulletin/archives/78(6)811.pdf. Note that there is a major differ-
ence between the size of the population and the portion of medical care a country consumes.
The best example is the United States, which accounts for half of all worldwide health care
spending each year.
3. DIETER GIESEN, INTERNATIONAL MEDICAL MALPRACTICE LAW: A COMPARATIVE LAW
STUDY OF CIVIL LIABILITY ARISING FROM MEDICAL CARE (1988). In this well-known book, Pro-
fessor Giesen discusses cases from Australia, Austria, Belgium, Canada, England, France,
Germany, Ireland, New Zealand, Scotland, Switzerland, and the United States. Id. at IX, 756-
831 (noting scope of book and citing case law used throughout). The only less developed
countries represented are South Africa and Zimbabwe. Id. at 756. Nevertheless, Professor Gie-
sen has been hailed as one of the founders of comparative health law, and this work has long
been admired as trailblazing. Arnold J. Rosoff, Health Law at Fifty Years: A Look Back, 14
HEALTH MATRIX 197, 207 (2004); Harry D. Krause, Dedicatory Essay: Professor Dr. Dieter Giesen,
12 J. CONTEMP. HEALTH L. & POL'Y I, X (1995).
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health literature published in American law reviews' focuses mainly
on the usual suspects -Canada, the United Kingdom, France, Ger-
many, Japan, and Australia.'
This is not entirely unjustified. We tend to learn more about our-
selves by looking at similarly situated jurisdictions. The more coun-
tries differ, the harder it is to isolate variables in a sort of mental re-
gression analysis. Developing countries seem more foreign to us and
can be considerably more difficult to research.' And perhaps most
importantly, they often have different health policy predicaments
that require their limited attention and resources.! Developing coun-
tries may not have the luxury of worrying about medical
malpractice.'
But malpractice in developing countries is worth examining for a
few reasons. First, patients from the United States and other West-
ern countries increasingly live in or visit the developing world and
consume health care there.' So for self-interested reasons, we should
understand how these jurisdictions handle medical malpractice dis-
putes and the obstacles patients might encounter. 10
4. See generally Timothy S. Jost, Comparative and International Health Law, 14 HEALTH MA-
TRIX 141 (2004) (discussing the uptick in comparative and international health law scholarship
within the past decade and a half).
5. See, e.g., TIMOTHY S. JOST, READINGS IN COMPARATIVE HEALTH LAW AND BIOETHICS (2d
ed., 2007) (including materials and case law from China, Haiti, India, Peru, and Venezuela,
among others, but focusing mostly on the countries listed in the text). A 2005 symposium in
the Journal of Law, Medicine, and Ethics included one article on China, with the others focused
on these same usual suspects. Symposium, Medical Malpractice: U.S. and International Perspec-
tives, 33 J.L. MED. & ETHICS 411 (2005). A notable counterexample is the International Encyclope-
dia of Medical Laws, which includes monographs on several developing countries, including
China, Hungary, Malaysia, Peru, and Uruguay. INTERNATIONAL ENCYCLOPEDIA OF MEDICAL
LAW (Herman Nys ed., 2010).
6. I learned this lesson as a new academic when I tackled for a single article the medical
malpractice systems in three developing countries (India, Mexico, and Thailand) and Singa-
pore. Nathan Cortez, Recalibrating the Legal Risks of Cross-Border Health Care, 10 YALE J. HEALTH
POL'Y L. & ETHICS 1 (2010). For a critical, thoughtful analysis of how scholars should approach
comparative research in health care, see Theodore R. Marmor et al., Comparative Perspectives
and Policy Learning in the World of Health Care,7 J. COMP. POL'Y ANALYSIS 331 (2005).
7. Nathan Cortez, International Health Care Convergence: The Benefits and Burdens of Market-
Driven Standardization, 26 WIS. INT'L L.J. 646, 693 (2009).
8. Cortez, supra note 6, at 21.
9. See, e.g., Nathan Cortez, Patients Without Borders: The Emerging Global Market for Patients
and the Evolution of Modern Health Care, 83 IND. L.J. 71 (2008); Nicolas P. Terry, Under-Regulated
Health Care Phenomena in a Flat World: Medical Tourism and Outsourcing, 29 W. NEW ENG. L.
REV. 421 (2007); I. Glenn Cohen, Protecting Patients with Passports: Medical Tourism and the Pa-
tient-Protective Argument, 95 IOWA L. REV. 1467 (2010).
10. Cortez, supra note 6, at 5.
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Second, we should appreciate how medical malpractice law oper-
ates and evolves in different environments. Developing countries
may utilize legal and regulatory models that look nothing like ours.
And even if some jurisdictions derive from Western models-as in
the case of India's system deriving from English law-they may
function very differently in practice. Developing countries also tend
to have very different health care systems. Health insurance is less
common.n Cash transactions and other out-of-pocket payments
predominate.1 2 The informal health sector is often large and unregu-
lated. Public resources must confront public health crises like HIV,
AIDS, tuberculosis, and malaria. And developing countries must
operate within different financial constraints, which can affect all
aspects of medical liability, including the power dynamic between
doctors and patients, the ability to retain legal counsel, and the abil-
ity to find a medical expert who is willing to testify. Many of these
things we take for granted.
Finally, medical malpractice law in the developing world is worth
studying for its own sake. These jurisdictions struggle with the same
problems we do: how to maintain a fair and efficient system for ad-
judicating malpractice complaints-one that denies meritless claims
and compensates claims with merit while holding physicians ac-
countable, deterring negligence, uncovering mistakes, and encour-
aging quality care." These problems are just as important, if not
more so, in developing countries where physicians often enjoy
greater professional autonomy from regulators and more deference
from courts.
To these ends, this Article explores two contemporary examples
of how developing countries have reformed their medical malprac-
tice redressal systems. Both India, a common law jurisdiction, and
Mexico, a civil code jurisdiction, have reformed their systems in re-
cent years. India now uses quasi-judicial consumer forums that fea-
ture streamlined procedures, allowing patients to bypass India's
cumbersome civil courts. Mexico now uses a public medical arbitra-
tion system that allows parties to avoid litigating an archaic body of
law in its outmoded civil and criminal courts. I evaluate each as a
potential model for other developing countries, given the common
problems these countries face.
11. Mark V. Pauly et al., Private Health Insurance in Developing Countries, 25 HEALTH AFF.
369, 369 (2006).
12. Id. at 371.
13. ToM BAKER, THE MEDICAL MALPRACTICE MYTH 93-117 (2005).
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Although both systems offer an alternative to traditional civil liti-
gation, I conclude that Mexico's is a superior alternative for other
developing countries. Unlike India's consumer forums, Mexico's
public system for medical arbitration does not require patients to se-
cure medical records and procure expert testimony from reluctant
parties-two prerequisites that preclude many successful claims in
India and likely plague plaintiffs in many other developing coun-
tries. Of course, not every developing country can or should imple-
ment Mexico's system-even among similar jurisdictions it can be
unwise to superimpose policies from elsewhere.1 4 But we should
begin to consider how the other three-quarters of the world handles
medical malpractice disputes.
I. WORLDs APART
Before evaluating the models in India and Mexico, it is worth
pausing to appreciate just how much developing countries can dif-
fer from our own, and why these differences matter. Developing
countries often struggle with some combination of poverty, infec-
tious diseases, professional shortages, underdeveloped health sys-
tems, weak infrastructure, large informal economies, regulatory and
civil society deficits, and other problems that tend to be secondary
(if they exist at all) for most developed countries. I argue that these
differences make it more, not less important that patients have a real-
istic way to redress their medical grievances.
A. Poverty
Money is an obvious yet defining distinction between developed
and developing countries." Developing countries struggle with
poverty and resource constraints in a way that developed countries
simply do not.'" These fiscal realities limit what they can spend on
14. Theodore R. Marmor, Global Health Policy Reform: Misleading Mythology or Learning Op-
portunity?, in HEALTH POLIcY REFORM, NATIONAL VARIATIONS AND GLOBALIZATION 348, 362
(Christa Altenstetter & James Warner Bjorkman eds., 1997); McPake & Mills, supra note 2, at
811-12.
15. Indeed, the phrase "developing country" is often used to denote low- or middle-
income countries, or both. Although this usage can be imprecise-not every low- or middle-
income country has a growing, "developing" economy-I will use this phrase for the sake of
simplicity. See Mark V. Pauly et al., How Private, Voluntary Health Insurance Can Work in Devel-
oping Countries, 28 HEALTH AFF. 1778, 1778 (2009) (classifying "truly 'developing' countries" as
ones with "low but growing per capita incomes").
16. Hasna Begum, Poverty and Health Ethics in Developing Countries, 15 BIOETHICS 50, 50
(2001).
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health care and health infrastructure." Indeed, lower income coun-
tries often lack the basic resources "to afford even some of the most
effective care."'" And the higher income developing countries that
can afford to spend more on health care have chosen not to, for a va-
riety of complex political reasons. 9 Poverty is perhaps a meta-factor
that belies many, if not all, of the following problems.
B. Other Health Priorities
A second, related factor that distinguishes developing countries is
that they are often beset by other health policy priorities, which can
relegate patients' rights to a secondary or even tertiary concern.
HIV/AIDS, malaria, SARS, swine flu, and other infectious diseases
plague countries like India, China, and many African nations.20 For
example, in India, "someone dies every minute from tuberculosis."2 1
These countries may rightly dedicate more time and attention to
addressing public health crises than things like medical negligence.
C. Scarcity of Physicians
Developing countries often struggle with very low ratios of health
care professionals to the general population, which likely contrib-
utes to the reluctance to over-regulate them. The World Health Or-
ganization (WHO) identified fifty-seven countries that face crisis-
level shortages of health care professionals, many of which are low-
income, developing countries." These countries have an average of
1.1 doctors per thousand residents, compared to 13.2 in the United
States. 3 Of course, the countries with the lowest ratios are among
the world's very poorest.24 Many developing countries educate phy-
17. See Pauly et al., supra note 11, at 371.
18. Id. at 372.
19. See id. A notable exception is Cuba. See Julie M. Feinsilver, Cuba as a "World Medical
Power": The Politics of Symbolism, 24 LATIN AM. RES. REV. 1, 4-6 (1989).
20. See Cortez, supra note 6, at 40 (explaining some of these crises in India).
21. Id. (citing Rueben Granich et al., Tuberculosis Control in India, 3 LANCET INFECTIOUS Dis-
EASES 595, 595 (2003)).
22. See WORLD HEALTH ORG., GLOBAL HEALTH WORKFORCE ALLIANCE, LIST OF 57 COUN-
TRIES FACING HUMAN RESOURCES FOR HEALTH CRISIS (AS IDENTIFIED BY THE 2006 WORLD
HEALTH REPORT), http://www.who.int/workforcealliance/countries/57crisiscountries.pdf
(last visited Dec. 6, 2011); Global Health Observatory, Health Workforce, WORLD HEALTH ORG.,
http://www.who.int/gho/health-workforce/en/index.html (last visited Dec. 6, 2011).
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sicians and nurses locally, only to watch them leave and "alleviate
shortages in Australia, North America, and Europe," which contrib-
utes to the shortages in those developing countries.2 This scarcity of
physicians can create a monopoly atmosphere26 that gives health
care professionals leverage to deter meaningful external regulation
or accountability. Indeed, many patients in developing countries
may be grateful to receive any care at all,27 even if it is substandard.
D. Immature Health Care Systems
Another important distinction is that developing countries often
have immature, underdeveloped health care systems. Their public
insurance schemes are often weak and underfunded, leading to sig-
nificant out-of-pocket spending.' Among twenty-one developing
countries sampled by Mark Pauly and colleagues, out-of-pocket
spending ranged from 38% to 84% of all health care spending, with
many countries in the 50-60% range. 29 By contrast, out-of-pocket
spending accounts for just 13% of all health spending in the United
States.3 ' These data are symptomatic of inadequate health infrastruc-
ture, including the public capacity to organize and regulate health
care financing. And, compounding the problem, developing coun-
tries frequently lack the expertise and resources necessary to con-
duct their own health policy research,1 which limits their ability to
self-reflect and generate reforms from within.
E. Large Informal Sectors
Another distinction between developed and developing countries
is that a large proportion of health spending in developing countries
goes to providers in the informal economy.2 In India, for example,
25. Pauly et al., supra note 11, at 372 (citing multiple studies, including Fitzhugh Mullan,
The Metrics of the Physician Brain Drain, 353 NEw ENG. J. MED. 1810 (2005)); see also Cortez, su-
pra note 9, at 109-10 (describing the "brain drain" from developing to developed countries).
26. Begum, supra note 16, at 53.
27. Id. at 56.
28. Pauly et al., supra note 11, at 370 (listing twenty-one developing countries' percentage
of gross domestic product spent out-of-pocket on health care).
29. Id. at exhibit 1.
30. Id. at 371.
31. See Miguel A. Gonzalez Block & Anne Mills, Assessing Capacity for Health Policy and Sys-
tems Research in Low and Middle Income Countries, 1 HEALTH RES. POL'Y & SYS. 1 (2003),
http://health-policy-systems.com/content/1/1/1.
32. See Anne Mills et al., ihat Can Be Done About the Private Health Sector in Low-Income
Countries?, 80 BULL. WORLD HEALTH ORG. 325, 325 (2002) (noting that the private sector in
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"[u]ntrained local practitioners and drug shop owners have grown
into the dominant type of provider of outpatient medical care.""
These providers are often called "rural medical practitioners, village
doctors, quacks, and other names" and generally fly under the radar
of regulators.'
Observers express concerns about the quality of care provided by
informal health practitioners." But patients use them because they
can be much less expensive and more accessible, and patients may
lack the requisite knowledge and information to choose higher-
quality providers." Unfortunately, studies show that practitioners
without formal medical training and credentials generally provide
poor-quality care." In India, most providers in the informal econo-
my "are seen to have a poor knowledge base and tend to follow irra-
tional, ineffective, and sometimes even harmful practices when
treating minor ailments."3 8 And because these providers tend to op-
erate locally and individually, they are much harder to regulate and
hold accountable.
F. Regulatory Deficits
Developing countries largely lack the regulatory capacity to set
and enforce standards on health care providers. In contrast, devel-
oped countries, like the United States, can rely on overlapping lay-
ers of laws and regulations to encourage physicians, hospitals, and
other providers to meet at least some minimum standards." But
even the larger, wealthier developing countries, like India and Chi-
low-income countries includes "[1]arge and small commercial companies, groups of profes-
sionals such as doctors, national and international nongovernmental organizations, and indi-
vidual providers and shopkeepers."); Pauly et al., supra note 15.
33. Gerald Bloom et al., Regulating Health Care Markets in China and India, 27 HEALTH AFF.
952, 954 (2008).
34. Id.
35. Mills et al., supra note 32, at 326. Of course, the quality of care is difficult to measure,
and can be even moreso in developing countries. Jishnu Das & Paul J. Gertler, Variations in
Practical Quality in Five Low-Income Countries: A Conceptual Overview, 26 HEALTH AFF. w296,
w297, w303 (2007) ("The overall quality of care documented in [studies on developing coun-
tries] is low."); Lilani Kumaranayake et al., How Do Countries Regulate the Health Sector? Evi-
dence from Tanzania and Zimbabwe, 15 HEALTH POL'Y & PLAN. 357, 357 (2000).
36. Mills et al., supra note 32, at 326.
37. Das & Gertler, supra note 35, at w308.
38. Bloom et al., supra note 33, at 958.
39. Nathan Cortez, Embracing the New Geography of Health Care: A Novel Way to Cover Those
Left Out of Health Reform, 84 S. CAL. L. REV. 859, 897-98 (2011).
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na, lack an overall framework for regulating their health sectors.
For example, in theory, India can rely on the Medical Council of In-
dia, various Departments of Health, the Indian Medical Association,
and other regulatory or quasi-regulatory bodies to oversee practi-
tioners.4' But self-regulation by professional medical societies is
weak and ineffectual.42 Instead of sanctioning recalcitrant members,
medical societies are more likely to ignore and minimize their be-
havior.43 Many developing countries focus on regulating licensing
and entry into the medical professions, rather than reviewing
medical professionals' performance retrospectively." As a result,
medical professionals can escape meaningful regulation in these
jurisdictions.
Aside from regulating medical professionals, developing coun-
tries often lack effective hospital regulation" and consumer protec-
tion regimes.
Some of the regulatory deficits in developing countries may be at-
tributable to timing-the health sectors in these countries have
grown considerably over the last few decades without a correspond-
ing growth in their regulating capacity.47 Many countries spent
years or even decades pouring money into their public health care
systems and, after their inevitable decline in public spending, the
private health sector grew to meet demand.48 Thus, developing
countries now have large, often thriving private health sectors that
are insufficiently regulated, if not completely unregulated.
Ultimately, legal redress is particularly important in developing
countries precisely because of their weak regulatory oversight of the
health industry and professions.
40. Bloom et al., supra note 33, at 953.
41. Id. at 957; Cortez, supra note 6, at 36-38.
42. I have analyzed how weak self-regulation by physicians is in India and Thailand. Cor-
tez, supra note 6, at 36-38, 52-56; see also Bloom et al., supra note 33, at 954.
43. Cortez, supra note 6, at 36-38, 52-56.
44. See Kumaranayake et al., supra note 35, at 360, 364 (noting this emphasis in Tanzania
and Zimbabwe).
45. See Cortez, supra note 6, at 23 n.128 (examining hospital accreditation in India).
46. See Mills et al., supra note 32, at 327.
47. See generally Bloom et al., supra note 33 (observing this trend in both China and India).
48. See id. at 954, 957-58. See generally Cortez, supra note 7 (surveying the rise of market-
driven medicine and private sector participation throughout the world).
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G. Insignificant Private Insurance Markets
An underappreciated regulatory deficit in developing countries is
the lack of a robust private health insurance market. Private insur-
ance can act as a channel for regulation.4 9 In developed countries
like the United States, both public and private insurers often use
their contracts with health care providers to "pursue regulatory ob-
jectives""o such as patient safety and quality outcomes. Insurers
often leverage their purchasing power to protect their
customers - patients.
In contrast, providers in developing countries often lack such in-
centives. A study of India and China found that private insurance is
an "underused" regulatory mechanism in both countries." As noted
above, a large chunk of health spending in these countries is out-of-
pocket.52 In India, "only 3-5% of Indians are covered by any form of
health insurance." Again, developing countries lack a key layer of
regulation that is relatively common in developed countries.
H. Weak Civil Societies
If a country cannot regulate its health practitioners -or if its ef-
forts are not legitimate, institutionalized, and above all enforced'-
then the public might fall back on civil society and civil institutions
for support. Unfortunately, many developing countries lack strong
civil societies to account for their regulatory deficits." The media
can be crucial at uncovering and raising public awareness of medi-
cal negligence, and fortunately, some developing countries, such as
India, have a relatively strong media." But not all developing coun-
tries can count on their media in such a manner. In addition, the
media often relies on court decisions and other formal adjudications
to inform them of medical malpractice. Accordingly, such circum-
49. See Cortez, supra note 39, at 910-13.
50. Bloom et al., supra note 33, at 953; Cortez, supra note 39, at 907-10.
51. Bloom et al., supra note 33, at 953.
52. Id.
53. Id. at 959.
54. Jennifer Prah Ruger, Global Health Governance and the World Bank, 370 LANCET 1471,
1473 (2007).
55. Id. at 1471-74.
56. Bloom et al., supra note 33, at 953, 961-62 (noting the absence of a strong civil society in
China but the presence of one in India).
57. Id. at 954.
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stances amplify the need for patients in developing countries to
have a genuine avenue for redressing their medical complaints.
I. Patients as Regulatory Sentinels
Rounding out this picture, patients in developing countries are
less equipped than patients in the developed world to act as regula-
tory sentinels, uncovering and reporting medical negligence. Pa-
tients in these countries are less able to access, process, and under-
stand information about the medical care they receive.5 8 For exam-
ple, many patients in the developing world who rely on informal
practitioners are frequently unaware that they are not professionally
trained.59 The information asymmetries between patients and pro-
viders can be particularly severe in developing countries, which fur-
ther distorts the power dynamic between them."o Patients in poverty
are even less likely to have the requisite literacy, education, and fi-
nancial resources to challenge their doctors.61 Some believe that
medical professionals unethically exploit these imbalances.6 2 If pa-
tients cannot appraise the quality or value of the care they receive,
then they are much less likely to serve as early sentinels. Developing
countries thus lack a key layer of -patient surveillance on
practitioners.
Compounding matters, residents of developing countries may be
reluctant to sue because they are either unaware of their legal rights,
feel powerless to invoke their legal rights against medical profes-
sionals or institutions, or have other cultural aversions to litigation.
My prior research on India, Thailand, Singapore, and Mexico found
significant reluctance to sue, widespread distrust of courts, and gen-
eral atmospheres that seemed to reinforce these misgivings rather
than counteract them.M
58. See McPake & Mills, supra note 2, at 813.
59. Bloom et al., supra note 33, at 958.
60. Id. at 953.
61. Begum, supra note 16, at 51 n.1 (noting that only 32.4% of the Bangladeshi population is
literate).
62. Id. at 51-52.
63. Id. at 52.
64. Cortez, supra note 6, at 23 (India), 45-47 (Thailand), 58, 62-64 (Singapore), 73 (Mexico).
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J. Context and Beyond
With this menu of problems in mind, it is worth noting that de-
veloping countries are far from monolithic. There can be crucial dif-
ferences between impoverished, low-income countries and develop-
ing, middle-income countries.' These distinctions can affect "the
capacity of the public sector to regulate, monitor, and negotiate with
the private sector," among other things.66
Focusing on health care quality in developing countries is long
overdue. For the last twenty-five years, the priority in most develop-
ing countries has been to expand access to health care." But now
that health care usage rates have crept upwards in the developing
world, even among lower-income residents, it is time to shift atten-
tion to the quality of care they receive. 68 This includes lower-income
residents' legal rights if the care they receive is substandard. Medi-
cal negligence can truly devastate patients in developing countries,
as these patients lack the social and economic safety nets that we en-
joy in developed countries. Unfortunately, these patients often face
significant barriers to redress.
II. BARRIERS To REDRESS IN THE DEVELOPING WORLD
As important as it is to redress malpractice in developing coun-
tries, it is equally difficult to effectuate a malpractice claim. Patients
in these jurisdictions frequently face four types of obstacles.
First, patients often struggle to secure their own medical experts
in adversarial litigation. Expertise may be scarce or unaffordable.
Physicians may be unwilling to testify against other physi-
cians-known as the "conspiracy of silence."69 In jurisdictions that
require plaintiffs to prove negligence, this burden can be insur-
mountable without an expert who is willing to testify that the de-
fendant breached the standard of care.70
Second, and somewhat related, medical malpractice claims are
difficult to prove in developing countries that do not grant patients
65. See McPake & Mills, supra note 2, at 813.
66. Id.
67. Das & Gertler, supra note 35, at w296; Kumaranayake et al., supra note 35, at 359 (noting
Zimbabwe's policy emphasis post-independence).
68. Das & Gertler, supra note 35, at w296-w297.
69. See, e.g., Cortez, supra note 6, at 28-29, 58, 63 (noting difficulties in India and Singapore,
respectively).




access to their medical records. For example, in India and Thailand,
patients are routinely denied access to even basic information about
their diagnoses and treatments.' Self-regulation by medical societies
has not significantly changed physician practices.72 At an institu-
tional level, hospitals and other health care facilities may not be re-
quired by licensing bodies to divulge information to patients or their
families." Facilities are even known to fabricate excuses for not pro-
ducing records, such as claiming disappearance. 74 Without proper
documentation, plaintiffs will struggle to carry their burden of
proof.
A third obstacle for plaintiffs in developing countries is navi-
gating an underdeveloped body of law. For example, legal experts
in both Thailand and Mexico lament that the law governing person-
al injuries in general (and medical malpractice, in particular) is thin
and antiquated. In Thailand, courts have few sources of guidance
in malpractice cases, as there are very few statutes, books, or articles
that discuss malpractice jurisprudence. In Mexico, legal scholars
have called the personal injury laws "scant," "skeletal," "obsolete,"
"simplistic," and "arcane."' Judges in these jurisdictions might be
reluctant to blaze new trails for plaintiffs because virtually every ju-
risdiction seems to be concerned about out-of-control medical mal-
practice lawsuits, whether justified or not. Moreover, where there
is law, it is not always favorable. Many common law jurisdictions
require judges to grant considerable deference to medical experts.
This is particularly true in India and other former British colonies
that follow English opinions like Bolam v. Friern Hospital Management
Committee,' discussed below.
71. Id. at 29-31, 44 (referring to patients in India and Thailand, respectively).
72. Id.
73. Bloom et al., supra note 33, at 959.
74. Cortez, supra note 6, at 44.
75. Id. at 43, 71-72 (discussing Thailand and Mexico, respectively).
76. Id. at 43 (citing S. Saithanu et al., Management of Medical Liability in Thailand, 12 J.
HEALTH SC. 876 (2003) (Thai.)).
77. Jorge A. Vargas, Mexican Law and Personal Injury Cases: An Increasingly Prominent Area
for U.S. Legal Practitioners and Judges, 8 SAN DIEGO INT'L L.J. 475, 478, 487-88, 499 (2007); Cor-
tez, supra note 6, at 71.
78. Cortez, supra note 6, at 49, 63-64 (noting fears of a malpractice crisis in Thailand and
Singapore, respectively).
79. [1957] 1 W.L.R. 582 (Q.B.) (Eng.); JOST, supra note 5, at 113-15 (citing Dieter Giesen,
Medical Malpractice and the Judicial Function in Comparative Perspective, 1 MED. L. INT'L 3, 4-7
(1993)).
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Fourth, patients in developing countries often have problems with
access to justice. These jurisdictions frequently struggle with mas-
sive case backlogs, weak judicial institutions, inadequate legal infra-
structure, corruption, and other problems endemic to the develop-
ing world."0 For many of these reasons, parties in developing coun-
tries often prefer to settle their disputes informally."
Overall, then, it should not surprise us that researchers have
found that courts "have played a limited role in influencing health
care practices" in some developing countries.8 2 At the risk of super-
imposing Western values on these jurisdictions, 83 it is important that
patients have a venue for adjudicating their grievances. Perhaps de-
veloping countries should explore alternative dispute resolution,8
as Mexico has.
III. COMPETING MODELS: INDIA AND MEXICO
Both India and Mexico have reformed their medical malpractice
systems in response to well-known deficiencies in their civil courts.
In this part, I evaluate both countries' reforms as potential models
for other developing countries.
A. India
Patients injured by medical malpractice in India can seek redress
in one of two venues-sue in a consumer forum or sue in civil
court.8 The latter is not much of an option.86 Plaintiffs can sue for
80. Ronald J. Daniels & Michael Trebilcock, The Political Economy of Rule of Law Reform in
Developing Countries, 26 MICH. J. INT'L L. 99, 119 (2004); William E. Davis et al., Implementing
ADR Programs in Developing Justice Sectors: Case Studies and Lessons Learned, 16 DIsP. RESOL.
MAG. 16, 16 (2010).
81. Ross Cranston, Access to Justice in South and South-East Asia, in GOOD GOVERNMENT AND
LAW: LEGAL AND INSTITUTIONAL REFORM IN DEVELOPING COUNTRIES 233 (ulio Foundez ed.,
1997).
82. Bloom et al., supra note 33, at 961 (discussing differences between health care in India
and China and possible approaches to health care financing in those countries).
83. See generally Thomas A. Kelley, Exporting Western Law to the Developing World: The Trou-
bling Case of Niger, 39 GEO. WASH. INT'L L. REV. 321 (2007) (explaining the Western world's re-
cent trend of imposing its policy reforms on the developing world).
84. See Davis et al., supra note 80, at 16 (citing over a decade of work on alternative dispute
resolution alternatives in Latin America and the Middle East and using El Salvador as a case
study).
85. Cortez, supra note 6, at 23. This section builds on my previous research, which ana-
lyzed the redressal options for medical malpractice victims in India, and whether U.S. patients
treated there can recover adequate compensation. See id. at 21-40.
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malpractice in India's civil courts under the Fatal Accidents Act,
which compensates the families of those killed by an "actionable
wrong," defined as death caused by a "wrongful act, neglect, or
default.""
Those lucky enough to survive can sue in civil court for common
law negligence." India inherited its common law system from the
English, so it uses a familiar formula that requires tort plaintiffs to
establish duty, breach, causation, and damages.89 Unfortunately for
medical malpractice plaintiffs, Indian courts also follow English
precedents," including the infamous Bolam decision that helps
courts determine the standard of care.91 Bolam and its progeny re-
quire courts to defer almost completely to medical experts when as-
certaining the appropriate standard of care in each case--essentially
requiring a defense verdict if any medical expert concludes that the
defendant acted reasonably, regardless of whether the expert's opin-
ion is not persuasive or is outweighed by conflicting expert testimo-
ny.92 The Bolam line of cases has neutered Indian courts,93 making it
difficult for plaintiffs to prove medical negligence.
Civil litigation in India is also known for its interminable delays.
Plaintiffs may wait ten, twenty, or even twenty-five years for cases
to conclude.94 Such delays undoubtedly deter many would-be plain-
tiffs. Authors have documented other reasons why India's civil
courts are inhospitable to medical malpractice claims,95 and in ag-
gregate, these obstacles make it difficult for plaintiffs to recover in
civil courts.
86. See id. at 34-36 (explaining how civil courts in India are infamous for their delays, tak-
ing up to twenty years to conclude certain cases).
87. The Fatal Accidents Act § 1A, No. 13 of 1855, INDIA CODE (1993), available at
http://indiacode.nic.in.
88. Cortez, supra note 6, at 35.
89. Id.; R.K. Nayak, Medical Negligence, Patients' Safety and the Law, 8 REG'L HEALTH FORUM
15, 20-22 (2004).
90. Nayak, supra note 89, at 20; Sidhartha Satpathy & Sujata Satpathy, Medical Negligence or
Diagnostic Conundrum? - A Medico-Legal Case Study, 21 MED. & L. 427, 428 (2002).
91. Bolam v. Friern Hosp. Mgmt. Comm., [1957] 1 W.L.R. 582, 593 (Q.B.) (Eng.); see also Bo-
litho v. City & Hackney Health Auth., [1998] A.C. 232, 239 (H.L.) (appeal taken from Eng.).
92. Bolam, 1 W.L.R. at 593. See Kumaralingam Amirthalingam, Judging Doctors and Diag-
nosing the Law: Bolam Rules in Singapore and Malaysia, 2003 SING. J. LEGAL STUD. 125, 137.
93. Cortez, supra note 6, at 57-62.
94. Bhatnager v. Surrendra Overseas Ltd., 52 F.3d 1220, 1228 (3d Cir. 1995) (reporting that
Indian legal experts provided statistical and anecdotal evidence that the "average" case heard
by the Calcutta High Court could last fifteen to twenty years); Sanjay Kumar, India: Doctors
Dispute Trader Role, 340 LANCET 1400, 1400 (1992).
95. See Cortez, supra note 6, at 34-36.
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The second avenue for redressing medical malpractice in India is
to file a complaint in its consumer forums, also known as Consumer
Disputes Redressal Agencies (CDRAs).96 India originally created its
consumer forums as an alternative to civil courts in general, not as a
venue for resolving medical malpractice claims. India's 1986 Con-
sumer Protection Act implemented the United Nation's 1985 Con-
sumer Protection Resolution, which called for signatories to
strengthen their consumer protection laws and enact "measures en-
abling consumers to obtain redress." 97 The Resolution was targeted
at developing countries like India.98 A major goal of both the Resolu-
tion and the Act was to create a more accessible, realistic alternative
for adjudicating consumer grievances, like complaints for receiving
defective goods or services. No one expected consumer forums to
become the main avenue for adjudicating medical malpractice
disputes.
Indeed, at first it was unclear whether the consumer forums even
had jurisdiction to hear medical malpractice cases. The forums be-
gan hearing general consumer complaints in 1987, but it was not un-
til 1992 that the National Consumer Disputes Redressal Commission
declared that the Act covered medical services." It took another
three years for the Indian Supreme Court to confirm this interpreta-
tion."oo Since then, the medical community in India has become in-
timately familiar with the Act,"o' frequently citing it as a "source of
anxiety."102
India's Parliament designed the consumer forums to be a quicker,
more economical, and more accessible alternative to civil courts.103
To achieve these goals, India structured the consumer forums as
quasi-judicial forums, vested with the imprimatur of the govern-
ment, along with various judicial powers-but without the full pan-
oply of powers that civil or criminal courts enjoy.1" For example, fo-
rums may summon witnesses and receive documentary evidence,
96. Consumer Protection Act, No. 68, Acts of Parliament, 1986. See Cortez, supra note 6, at
23.
97. G.A. Res. 39/248, U.N. Doc. A/RES/39/248 (Apr. 16, 1985).
98. Id.; Cortez, supra note 6, at 24 n.134.
99. Cortez, supra note 6, at 24 n.136.
100. See Indian Med. Ass'n v. V.P. Shantha, A.I.R. 1996 S.C. 550.
101. See Ramesh Bhat, Regulation of the Private Health Sector in India, 11 INT'L J. HEALTH
PLAN. & MGMT. 253, 262 (1996).
102. Kumar, supra note 94, at 1400; Cortez, supra note 6, at 24.
103. See Bhat, supra note 101, at 264.
104. Cortez, supra note 6, at 24.
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including affidavits and laboratory results,"os but the forums seem
reluctant to handle more complex cases.o' The forums use panels of
professional adjudicators rather than juries, and the members can
have judicial or non-judicial training and experience.'07
The Consumer Protection Act created district, state, and national
consumer forums. Each forum has primary jurisdiction to hear
complaints, and the state and national forums also have appellate
jurisdiction to hear appeals from below."s Original jurisdiction de-
pends on the amount of compensation the plaintiff seeks: the rough-
ly 600 District Forums have jurisdiction over matters involving up to
two million rupees in claimed compensation (roughly $44,300); 34
State Commissions have jurisdiction over matters involving up to
ten million rupees (roughly $221,400); and the National Commission
has jurisdiction to hear matters involving more than ten million
rupees.10 9
The Consumer Protection Act itself created causes of action for
consumer forums to resolve."0 Medical malpractice plaintiffs typi-
cally file complaints for "deficient" medical services, defined as
"any fault, imperfection, shortcoming or inadequacy in the quality,
nature and manner of performance.""' Legal scholars in India inter-
pret this to require simple negligence,112 though it seems redundant
with section 14 of the Act, which awards compensation for negli-
gence as well."'
105. Consumer Protection Act, No. 68, Acts of Parliament, 1986.
106. Herambalal Das v. Dr. Ajoy Paul, (2001) 2 C.P.R. 498, 498; Cortez, supra note 6, at 34.
107. Cortez, supra note 6, at 24-25 (citing Consumer Protection Act § 10(1)(a) by way of
example).
108. Consumer Protection Act §§ 9-27A.
109. Id. §§ 11(1), 17(1)(a)(i), 21(a)(i). The dollar amounts were calculated using the United
States Federal Reserve Bank's database of foreign exchange rates for the Indian rupee. See His-
torical Rates for the Indian Rupee, BD. OF GOVERNORS OF THE FED. RESERVE, http://www
.federalreserve.gov/releases/h10/hist/datO0_in.htm (last visited Dec. 6, 2011) (using data for
May 27, 2011, showing that 45.17 rupees equaled one dollar). For information on the structure
and number of consumer forums, see Addresses of the State Consumer Disputes Redressal Com-
missions, NAT'L CONSUMER DISPUTES REDRESSAL COMM'N, http://www.ncdrc.nic.in
/sDetails.html (last visited Dec. 6, 2011). See also District Forums, NAT'L CONSUMER DISPUTES
REDRESSAL COMM'N, http://www.ncdrc.nic.in/districtforums.html (last visited Dec. 6, 2011).
110. Consumer Protection Act §§ 2(c)(i)-(vi).
111. Id. § 2(c)(iii), (g).
112. See Bhat, supra note 101, at 265; K.K.S.R. Murthy, Medical Negligence and the Law,
4 INDIAN J. MED. ETHICS 116, 116-17 (July-Sept. 2007), available at
http://www.issuesinmedicalethics.org/pdfs/153oall6.pdf; Talha Abdul Rahman, Medical
Negligence and Doctors' Liability, 2 INDIAN J. MED. ETHICS, (Apr.-Jun. 2005), available at
http://www.issuesinmedicalethics.org/132hl060.html.
113. Consumer Protection Act § 14(1)(d).
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The forums may award different types of compensation, includ-
ing compensatory damages, punitive damages (where appropriate),
and costs,"4 but they generally do not award noneconomic damages
like pain and suffering."s During my prior research, I did not find
evidence that courts award punitive damages or costs very often."'
The Act creates streamlined adjudications, calling for forums to
resolve complaints within five to six months after being filed."1
Plaintiffs have two years to file a complaint after the cause of action
arises, though forums can waive that requirement if the plaintiff
shows cause.1 After receiving the defendant's response, the forum
must resolve the case within three months,11 9 bringing the adjudica-
tion to the five or six month total.
Of course, these statutory deadlines are infrequently met in prac-
tice, despite national regulations calling for forums to clear a certain
percentage of cases each month.120 Thus, consumer forum cases typ-
ically take two to three years to be resolved.121 Although this still
compares very favorably to civil courts, it is not the quick six-month
adjudication that the Act contemplates.
India's use of consumer forums certainly has been an antidote to
its notoriously inefficient civil courts, but the forums are not ideal
venues for resolving medical malpractice claims. Plaintiffs must
overcome two significant, if not insurmountable, obstacles.
First, patients in India often struggle to find a medical expert will-
ing to testify that another physician was negligent. Whether this is a
matter of physician scarcity in India-there are only 0.6 physicians
per thousand residents in India, and the WHO listed India as one of
the fifty-seven countries facing crisis-level shortages of health care
114. Id.
115. Cortez, supra note 6, at 31 (citing Harjol Ahluwalia v. Spring Meadows Hosp., (1986)
199 Consumer 4457; Spring Meadows Hosp. v. Harjol Ahluwalia, (1998) 4 S.C.C. 39); Charan
Singh v. Healing Touch Hosp., A.I.R. 2000 S.C. 3138, 3142.
116. See Cortez, supra note 6, at 31-32.
117. See Consumer Protection Act §§ 12-14.
118. Id. §§ 24A(1)-(2).
119. See id. § 13(3A).
120. Consumer Protection Regulations, 2005, 342(E) Gen. S. R. & 0. § 19(1), available at
http://ncdrc.nic.in/Regulations2005.htmL.
121. Tim Ensor & Sabine Weinzierl, Regulating Health Care in Low- and Middle-Income Coun-
tries: Broadening the Policy Response in Resource Constrained Environments, 65 Soc. SCI. & MED.
355, 363 (2007); K.T. Sangameswaran et al., Consumer Laws Implementation, HINDU, Nov. 6,




professionalsl2-or the "conspiracy of silence,"" this is likely a ma-
jor problem in many other developing countries as well. In India,
most plaintiffs ultimately fail to present any kind of expert testimo-
ny.124 Conversely, defendants seem to have no problem finding col-
leagues to testify. These realities combine to make it very difficult
for plaintiffs to carry their burden of proving that a physician was
negligent and thus provided "deficient" services under the Act.123
The scarcity of plaintiff-friendly medical experts is not necessarily
a design problem with India's consumer forums. Virtually any ad-
versarial system that relies on experts to set the standard of care in
tort cases will pivot on the ability of adversaries to find experts will-
ing to testify. For that reason, some in India have proposed solu-
tions, such as using independent advisory panels on medical negli-
gence cases,12 6 using special panels staffed with medical experts to
hear all malpractice cases once a month, or requiring each panel in
these cases to have at least one medical expert on staff.127 Neverthe-
less, my research on India's consumer forums has not found any
major movement to address this problem.12
The second obstacle for malpractice plaintiffs in India's consumer
forums is obtaining medical records. Physicians and hospitals in In-
dia often refuse to hand over documents to patients suing them, in-
cluding even basic information about their course of treatment or
the medications they receive. 129 For a long time, no laws in India re-
quired providers to maintain such records or disclose them to pa-
tients.1 30 A 1996 opinion by the Bombay High Court held that medi-
cal providers must give records to patients or their families, but this
opinion did not ignite a revolution.' In 2002, the Indian Medical
122. Global Health Observatory, Total Density of Physicians Per 1,000 Population, Latest
Available Year, WORLD HEALTH ORG., http://www.who.int/gho/health workforce
/physicians density/en/index.html (last visited Dec. 6, 2011); WORLD HEALTH ORG., GLOBAL
HEALTH WORKFORCE ALLIANCE, supra note 22.
123. JOST, supra note 5, at 121.
124. Bhat, supra note 101, at 265.
125. ANOOP KAUSHAL, MEDICAL NEGLIGENCE AND LEGAL REMEDIES, 12,26 (2004).
126. Debashis Konar, Courting Crisis: Medico Cases in the Docks, TIMES INDIA, Apr. 23, 2005,
available at 2005 WLNR 6358838.
127. See KAUSHAL, supra note 125, at 6-7.
128. Cortez, supra note 6, at 28-29.
129. Nayak, supra note 89, at 22; Bhat, supra note 101, at 265.
130. KAUSHAL, supra note 125, at 24; see generally Nayak, supra note 89, at 19-22 (explaining
how patients' rights in India are only indirect rights).
131. Raghunath G. Raheja v. Maharashtra Med. Council, 1996 A.I.R. 198 (Born.) 203; K.
Mathiharan, Medical Records, 1 INDIAN J. MED. ETHICS (Apr.-June 2004), available at
http://www.issuesinmedicalethics.org/122hl059.html.
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Council finally created regulations that require practitioners to keep
records for at least three years and disclose them to patients, 3 2 but
my research did not find evidence that the Council enforces them.13
Finally, the National Commission has held that a hospital is not re-
quired to maintain or disclose medical records under the Consumer
Protection Act.' " There have been various calls to require hospitals
and physicians to disclose medical records to patients, 35 but not al-
ways for the benefit of patients.136 Thus, malpractice plaintiffs in In-
dia struggle to document what happened to them.
For these reasons, plaintiffs rarely succeed in bringing complaints
against physicians under the Consumer Protection Act. Various
sources report that plaintiffs lose between 70 and 90% of malpractice
cases in the consumer forums.1 3' A physician described the medical
malpractice atmosphere as "absolute chaos."' 3  Given these short-
comings, is there a better model for developing countries to follow?
B. Mexico
Patients in Mexico can sympathize with their counterparts in In-
dia. Mexico's civil courts are not a palatable option either. Fortu-
nately, as in India, the government has given patients an alternative.
Unlike India, Mexico is a civil code jurisdiction.139 Mexican courts
do not use familiar common law staples like juries or stare decisis.14
132. Med. Council of India, Code of Ethics Regulations, 2002, Gazette of India,
Apr. 6, 2002, § 1.3, available at http://www.mciindia.org/RulesandRegulations
/CodeofMedicalEthicsRegulations2002.aspx.
133. See Cortez, supra note 6, at 30, 36-38.
134. Poona Med. Found. v. Maruttrao Tikare, (1995) 1 C.P.R. 661.
135. Ganapati Mudur, Indian Doctors Not Accountable, Says Consumer Report, 321 BRIT. MED.
J. 588, 588 (2000) (describing how India's Central Consumer Protection Council "has periodi-
cally urged the Indian health ministry to make it mandatory for all hospitals to provide medi-
cal records to patients").
136. See Cortez, supra note 6, at 30 (describing the efforts of the Medical Council of West
Bengal, which amended its Code of Medical Ethics to require doctors to keep and disclose
medical records, in part to protect doctors during malpractice suits).
137. See id. at 10 (citing sources that plaintiffs lost 76% of cases reported by State Commis-
sions, the National Commission, and the Supreme Court between 1988 and 1998, 71% of cases
reported by the Gujarat State Commission between 1990 and 1994, and roughly 90% of cases
in district forums in a two-year period).
138. George Thomas, Consummate Justice or Complete Folly? Doctors and Consumer Protection
Act, 10 ISSUES MED. ETHICS, available at http://www.issuesinmedicalethics.org
/1021e028.html.
139. Vargas, supra note 77, at 486.
140. Id.
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Judges decide cases and are not really bound by any common law
precedents.
Traditional U.S.-style tort litigation is alien to Mexico and, as a
subset, medical malpractice litigation is exceedingly rare. 42 Personal
injury cases in Mexico are governed by the Federal Civil Code, or
one of the thirty-one state codes that largely track it.14' These codes
remedy personal injuries and deaths through "extra-contractual lia-
bility" that arises from illegal acts based on duties and obligations
owed to one another.144
As a civil code jurisdiction, Mexico's legislature, the Congress of
the Union, 145 is responsible for developing the law in the area of per-
sonal injury. However, as Mexican law expert Jorge Vargas has em-
.phasized, the legislature has largely neglected personal injury law.46
Only 35 of the over 3000 sections in the civil code address what we
would think of as tort law.14 7 Moreover, "the legal principles that
control personal bodily injuries and wrongful deaths in [Mexico]
have been kept in isolation and virtually untouched in a legal time
capsule that is today legally obsolete and completely out of sync
with Mexico's economic and industrial realities." 4 8 The Mexican
Congress "has not clarified when courts should find fault, negli-
gence, or causation," leaving significant discretion to the court in
each case.149 And Mexican courts cannot fill the void in the same
141. Note, however, that opinions by Mexico's Supreme Court and various Circuit Colle-
gial Courts have persuasive power over lower court judges. Jorge A. Vargas, An Introductory
Lesson to Mexican Law: From Constitutions and Codes to Legal Culture and NAFTA, 41 SAN DIEGO
L. REV. 1337, 1353 (2004). Legally binding precedents that satisfy certain procedural and sub-
stantive criteria are known as Jurisprudencias. Id. On factual issues, judges have significant dis-
cretion on what evidence to admit and how much weight to give it. Boris Kozolchyk & Martin
L. Ziontz, A Negligence Action in Mexico: An Introduction to the Application of Mexican Law in the
United States, 7 ARIz. J. INT'L & COMP. L. 1, 13 (1989).
142. Jorge A. Vargas, Tort Law in Mexico, in 2 MEXICAN LAW: A TREATISE FOR LEGAL PRAC-
TITIONERS AND INTERNATIONAL INVESTORS 214 (West Grp., 1998); Vargas, supra note 77, at 488.
143. Vargas, supra note 142, at 210-11; Vargas, supra note 77, at 478.
144. C6digo Civil Federal [CC] [Federal Civil Code], unamended, Diario Oficial de la Feder-
aci6n [DO], 26 de Mayo de 1928; Jorge Mario Magall6n Ibarra, La Responsibilidad Profesional de
los Medicos [The Professional Responsibility of Physicians], 1 MEx. L. REV. 45, 54 (2004).
145. See M. CONGRESO DE LA UNION: SISTEMA E-CONGRESO, http://www.congreso.gob
.rnx/ (last updated 2006).
146. Vargas, supra note 77, at 478-79.
147. Jorge A. Vargas, Moral Damages Under the Civil Code of Mexico, 35 INTER-AMERICAN L.
REV. 183, 186 (2004) (citing corresponding sections of the Code).
148. Vargas, supra note 77, at 487-88.
149. Cortez, supra note 6, at 72; see also Vargas, supra note 77, at 499-500 (noting that the
Mexican legislature grants significant discretion to judges to find negligence and that the Mex-
ican Supreme Court only briefly discusses these principles in its Jurisprudencias).
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way that common law courts can. Thus, Mexican law governing
personal injuries remains severely underdeveloped and outdated.
The way Mexican law calculates compensation also deters plain-
tiffs from using civil courts to redress medical malpractice claims.
As in India, laws in Mexico do not grant damages for noneconomic
injuries like pain and suffering."so Rather, the Civil Code requires
Mexican courts to calculate compensatory damages by using a statu-
tory workers' compensation formula.' This formula, found in the
Federal Labor Act, compensates injured plaintiffs as if they were
employees injured on the job.152 This allows courts to award the
costs of medical care incurred after the injury, for example, but lim-
its economic losses to four-times the minimum wage in that state for
the duration allowed for the corresponding disability in the Federal
Labor Act.153
For all these reasons, patients rarely bring malpractice cases in
Mexico's civil courts. In fact, Professor Vargas has found that U.S.
courts actually hear more personal injury cases arising from Mexico
than Mexican courts.'54 Culturally, there is widespread distrust of
courts and an aversion to litigation." Parties tend to settle personal
injury cases informally, and medical providers generally offer to
treat whatever harms they might have caused.
But as in India, an alternative emerged. In 1996, then-President
Ernesto Zedillo declared that a new national arbitration agency
would be formed within Mexico's Ministry of Health.1 6 Thus, the
National Commission for Medical Arbitration (Comisi6n Nacional
de Arbitraje M6dico, or "Conamed") was born.'
150. Vargas, supra note 77, at 479, 484 (noting that Mexican law does grant "moral damag-
es" as "equitable compensation," but this is limited to one-third of the amount of total liabil-
ity); Codigo Civil Federal [CC] [Federal Civil Code], as amended, art. 691, Diario Oficial de la
Federaci6n [DO] 31 de Agosto de 1928. But see Kozolchyk & Ziontz, supra note 141, at 34 (not-
ing that judges have significant discretion to award more than one-third of the total compen-
satory damages as moral damages).
151. Vargas, supra note 77, at 479.
152. Cortez, supra note 6, at 72; Vargas, supra note 77, at 478 (citing Ley Federal del Trabajo
[LFT] [Federal Labor Law], as amended, Diario Oficial de la Federaci6n [DO], Title IX, arts. 477-
80, 487, 491-93, 495-97, 500-02, 1 de Agosto de 1971 (Mex.)).
153. Vargas, supra note 77, at 479; Cortez, supra note 6, at 72.
154. See Vargas, supra note 77, at 478.
155. Id. at 502.
156. Magall6n Ibarra, supra note 144, at 47-48; Carlos Tena-Tamayo & Julio Sotelo, Mal-
practice in Mexico: Arbitration Not Litigation, 331 BRIT. MED. J. 448, 449 (2005).
157. For background information on Conamed, largely in Spanish, see COMISION NACION-
AL DE ARBITRAJE MDICO, http://www.conamed.gob.mx/index.php.
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Like India's consumer forums, Conamed was designed as a more
accessible, efficient, and less costly alternative to civil courts.s' But
unlike India's consumer forums, Conamed was designed specifical-
ly to handle disputes over medical care-a feature that developing
countries might emulate.
Conamed's primary charge is to mediate disputes between pa-
tients and providers,15 9 saving the parties from litigating in civil,
criminal, or administrative venues.6 o Conamed can resolve cases at
any one of these three stages.
Roughly 73% of cases are resolved at the first stage, within two
days of a conflict being submitted to Conamed."'' The first stage in-
volves an immediate, somewhat informal intervention that opens
the lines of communication between the patient and provider, some-
times involving one of Conamed's specialized consultants.1 62 This
relatively quick and informal initial intervention might be particu-
larly attractive to both patients and providers in developing coun-
tries that have a low tolerance-and few resources-for adversarial
litigation.
If the parties do not resolve their dispute during this initial inter-
vention, a complaint is filed with Conamed, and the case proceeds
to conciliation.163 Conamed's experts will screen complaints before
formally accepting them for conciliation, separating medical mal-
practice cases from disputes over other matters, like a physician re-
fusing to treat a patient.1 6 Conamed will advise the parties on the
latter, but will not admit complaints formally unless the dispute in-
volves allegations of malpractice.' This second, conciliatory phase
introduces a medical review by both Conamed's experts and the
treating physician(s)."' At this phase, the parties can sign a concilia-
tory agreement, opt out of the Conamed process and file a lawsuit,
158. See Cortez, supra note 6, at 6.
159. Magall6n Ibarra, supra note 144, at 47-48; Jorge Fernandez Ruiz, The National Commis-
sion of Medical Arbitration and the Responsibility of Civil Servants, 3 MEX. L. REV. 311; Tena-
Tamayo & Sotelo, supra note 156, at 449.
160. H6ctor Gerardo Aguirre-Gas et al., Quality of Medical Care and Surgical Patient Safety:
Medical Error, Malpractice and Professional Liability, 78 CIRUGIA Y CIRUJANOS [SURGERY AND
SURGEONS] 454,458 (2010).
161. Tena-Tamayo & Sotelo, supra note 156, at 450 (noting that 73% of the roughly 15,000
cases Conamed handled between 2001 to 2003 were resolved at this stage).
162. Id. at 449-50.
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or proceed to the last stage, arbitration.16 7 Between 2001 and 2003,
roughly 27% of cases proceeded to conciliation, over half of which
were resolved at this second stage, typically within three to six
months.'"
To arbitrate, the parties must sign an agreement that precludes
them from taking the case to court.169 The arbitrators are independ-
ent physicians or attorneys trained to handle these cases.170
Conamed supports the arbitrators by peer-selecting expert consult-
ants based on the medical issues in each case. Conamed thus en-
joys credibility both with the judicial and medical communities in
Mexico-it provides expert opinions for courts and consults with
hospitals about medical errors.1 72 This is a key component to its suc-
cess, and one that might be difficult to replicate for developing
countries with weaker pools of medical and legal experts. 73
If arbitrators conclude that the physician committed malprac-
tice-typically through "negligence or inexperience"-it can award
compensation, including damages, medical expenses, or cancelling
the patient's debt to the provider.1 74 Conamed arbitrators calculate
damages based on the same workers' compensation formula used in
the Civil Code, though arbitration awards are usually less than
those awarded by a court."' Conamed may not sanction physicians
and cannot award "moral damages" like civil courts can."' As a
counterbalance, patients avoid the costs of litigation. 77
Of the roughly 15,000 cases filed with Conamed between 2001 and
2003, only 81 (0.05%) were resolved by arbitration, taking an aver-
age of fifteen months to resolve." Over 10% of all cases filed during
167. Id.
168. Id. at 449-50 (noting that 2037 of the 3969 cases (51.3%) reaching conciliation are re-
solved in that stage).
169. Id.
170. Id. at 450.
171. Id.
172. Id. at 449-50. Conamed employees also publish studies in peer-reviewed journals un-
der their Conamed affiliations. See, e.g., Germin Fajardo-Dolci et al., Patient Safety Culture in
Healthcare Professionals, 78 CIRUGLA Y CIRUJANOS [Surgery and Surgeons] 522, 522 (2010).
173. See Tena-Tamayo & Sotelo, supra note 156, at 449.
174. Id. at 450 (citing Comisi6n Nacional de Arbitraje M6dico, Procedimiento Arbitral en la
Conamed, http://www.conamed.gob.mx (last visited Aug. 23, 2011)).
175. See id. at 449-50.
176. Id. "Moral damages" are equitable remedies available at the discretion of judges to
indemnify victims for noneconomic injuries. See generally Vargas, supra note 77 at 509.
177. Tena-Tamayo & Sotelo, supra note 156, at 449.
178. Id. at 449-50.
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that period were not resolved.179 Of those, Conamed estimates that a
third of complainants simply left the process, and "the remaining
unresolved cases probably went to court." 80
Conamed certainly is not perfect. Providers still win roughly two-
thirds of the cases surveyed.'"' The remaining third receives some-
what modest compensation-free treatment, costs, or financial com-
pensation (averaging only $4841 per patient).82 And it is not clear
whether or to what extent patients and physicians are represented
by counsel and if there is any discrepancy between the parties. In
that vein, Conamed is markedly less judicial than India's consumer
forums. Indeed, they are entirely different phenotypes, with
Conamed sharing much more in common with other arbitration
systems.
Overall, the parties before Conamed report high levels of satisfac-
tion with the process-Conamed received ratings of "good" or "ex-
cellent" by 97% of roughly 5500 patients and providers surveyed
anonymously by Conamed.'" I have never seen a similar survey of
U.S. medical malpractice plaintiffs and defendants, but it is probably
safe to say that those numbers might be the inverse of Conamed's.
CONCLUSION
Developing countries differ from ours in important ways, and
these differences suggest that it is particularly important for patients
to have realistic avenues to redress their medical grievances. India
and Mexico provide two different models, both of which depart
from traditional civil litigation. Mexico's model is a superior alterna-
tive to India's because Mexico eliminates the requirement that pa-
tients carry the burden of proof by securing medical records and ex-
pert testimony from reluctant parties. Mexico's system is also less
adversarial, which may better accommodate the fiscal and cultural
realities in developing countries.
179. Id.
180. Id.
181. Id. at 450; Maria-Eugenia Jimenez-Corona et al., Epidemiology of Medical Complaints in
Mexico: Identifying a General Profile, 18 INTL J. QUALITY HEALTH CARE 220, 221 (2006) (finding
evidence of malpractice in a similar ratio of randomly-sampled cases). However, a later retro-
spective study by Conamed found no evidence of malpractice in roughly 75% of over 8000
cases surveyed between 1996 and 2008, which suggests the success rate for patients should be
even lower. Aguirre-Gas et al., supra note 160, at 457.
182. See Cortez, supra note 6, at 75 (dividing $2.9 million awarded by Conamed between
2001 and 2003 by the 599 patients that received these payments).
183. Tena-Tamayo & Sotelo, supra note 156, at 451.
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However, developing countries are not monolithic, and countries
can organize, finance, and regulate health care much differently,
even within the same country.'" We cannot impose Western values
like U.S.-style "adversarial legalism," on developing countries. 85
Even stopping short of that American ideal, developing countries
have shown resistance to alternative dispute resolution.'
Nevertheless, medical malpractice litigation has social value,"'
particularly for developing countries in which physicians enjoy such
significant professional autonomy, monopoly-like benefits, and vir-
tually no meaningful state regulation. It is time that the comparative
literature embraces the cause in these jurisdictions.
184. Das & Gertler, supra note 35, at w297, w301 (referring to the diversity of health care
delivery among and within developing countries).
185. ROBERT A. KAGAN, ADVERSARIAL LEGALISM: THE AMERICAN WAY OF LAW 3-17 (2001)
(describing exceptionalism in the American desire for litigant-driven, rights-focused, formal
"adversarial litigation").
186. See Christine Cervenak et al., Leaping the Bar: Overcoming Legal Opposition to ADR in the
Developing World, 4 DISP. RESOL. MAG. 6 (1998) (describing resistance in Bangladesh, South Af-
rica, Sri Lanka, Ukraine, and Uruguay).
187. For a compelling argument that medical malpractice litigation has social value in the
United States context, see BAKER, supra note 13, at 6.
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